Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108,074,661
-
Total 13F shares
-
35,610,940
-
Share change
-
-1,942,014
-
Total reported value
-
$77,957,966
-
Price per share
-
$2.19
-
Number of holders
-
82
-
Value change
-
-$16,270,841
-
Number of buys
-
44
-
Number of sells
-
48
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock (ACRS) as of Q2 2019
As of 30 Jun 2019,
Aclaris Therapeutics, Inc. - Common Stock (ACRS) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,610,940 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FRANKLIN RESOURCES INC, BlackRock Inc., Man Group plc, Rock Springs Capital Management LP, Sofinnova Investments, Inc., VANGUARD GROUP INC, Vivo Capital, LLC, Endurant Capital Management LP, and MFN Partners Management, LP.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.